WHO ICTRP trial
The evaluation of the effect and safety of night serum in visible signs of aging
ISRCTN33018063 · International Standard Randomised Controlled Trial Number (ISRCTN) · Not Recruiting
Key facts
| Trial ID | ISRCTN33018063 |
|---|---|
| Public title | The evaluation of the effect and safety of night serum in visible signs of aging |
| Scientific title | Multicenter, open-label, clinical study evaluating the efficacy and safety of an antiaging night serum product applied once daily for improvement of visible aging signs in healthy subjects with moderate facial aging |
| Primary sponsor | ISDIN S.A |
| Registry | International Standard Randomised Controlled Trial Number (ISRCTN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Not Applicable |
| Countries | United States of America |
| Conditions | Skin with moderate signs of aging Skin and Connective Tissue Diseases |
| Interventions | Subjects were instructed to use the serum once a day at night on the face, neck and neckline for 12 weeks. On site n#2 subjects participated in an extension period to 24 weeks. Efficacy assessments were conducted on week 6, 12, 18 and 24… |
| Registration date | May 11, 2019 |
| Target size | 24 |
| Secondary IDs | Nil known;Nil known;ISD-AE652-01-2018 |
| Registry page | isrctn.com |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: